Civica

Partners Group to sell Civica, a global provider of cloud software solutions for the public sector

Retrieved on: 
Monday, December 25, 2023

Partners Group to sell Civica, a global provider of cloud software solutions for the public sector

Key Points: 
  • Partners Group to sell Civica, a global provider of cloud software solutions for the public sector
    Partners Group, a leading global private markets firm, acting on behalf of its clients, has agreed to sell Civica (or "the Company"), a global provider of cloud software solutions for the public sector, to Blackstone.
  • Headquartered in the UK, Civica provides cloud software solutions to over 6,000 organizations across seven countries that deliver critical services to citizens.
  • In partnership with Partners Group, we have significantly transformed our offering and increased growth momentum across cloud, digital enablement, software innovation, and data analytics.
  • Partners Group was advised by Clifford Chance as legal counsel and Arma Partners as exclusive financial adviser.

Edison issues update on Princess Private Equity Holding (PEY): Offering an attractive dividend yield

Retrieved on: 
Thursday, December 14, 2023

Princess Private Equity Holding (PEY) posted a year-to-date NAV total return to end-October 2023 of 4.9%, 2.4% of which was from Q323.

Key Points: 
  • Princess Private Equity Holding (PEY) posted a year-to-date NAV total return to end-October 2023 of 4.9%, 2.4% of which was from Q323.
  • PEY’s balance sheet remains firm with c €134m in undrawn credit facility and €3m in cash, further assisted by the Civica sale proceeds upon deal closure.
  • Consequently, PEY will pay out two interim dividends of €0.73 in total in 2023, implying a yield of 6.9% at the current share price.
  • We believe that PEY’s maturing portfolio could provide attractive exit opportunities once activity in the global M&A markets rebounds.

Bouwien Smits Joins Civica Rx as Site Vice President and General Manager of New Virginia Manufacturing Facility

Retrieved on: 
Wednesday, November 1, 2023

Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.

Key Points: 
  • Civica Inc. (Civica, Civica Rx) is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.
  • Smits has over 25 years of experience, including working with aseptic products and injectable drugs, alongside critical expertise in facility and equipment qualification, system implementation, and process validation.
  • “Bouwien is joining us at a critical moment in the startup process for Civica’s first manufacturing facility,” said Jay Benson, Civica’s Chief Manufacturing and Supply Chain Officer.
  • “The Petersburg facility will be transformative for ensuring safe and reliable supplies of medicines for hospital systems and patients and for bringing much needed affordability into the insulin marketplace.”
    Prior to joining Civica, Smits was Vice President of Quality at Sage Therapeutics.

Akamai Extends Its Industry-Leading DDoS Defense with Prolexic On-Prem and Hybrid Options Powered by Corero

Retrieved on: 
Wednesday, September 20, 2023

CAMBRIDGE, Mass., Sept. 20, 2023 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today announced a global partnership with Corero Network Security (LON: CNS), the specialists in distributed denial-of-service (DDoS) protection solutions. Akamai is now offering Corero's on-premises DDoS protection to extend Akamai Prolexic, Akamai's own comprehensive portfolio of DDoS security solutions.

Key Points: 
  • Akamai is now offering Corero's on-premises DDoS protection to extend Akamai Prolexic, Akamai's own comprehensive portfolio of DDoS security solutions.
  • According to Corero's threat research, DDoS carpet bombing attacks rose by 300% in 2022, and IPv6-based DDoS attacks increased by 500% during the same period.
  • Prolexic is a cloud-based DDoS protection platform designed to stop attacks before they reach applications, data centers, and internet-facing infrastructure.
  • The hybrid solution lets organizations bring DDoS defense on-premises while still getting the safety of Prolexic's massive cloud-based defense capacity to defend against large, sustained attacks.

Veeva Vault LIMS to Support Civica Rx Quality Control

Retrieved on: 
Tuesday, August 22, 2023

PLEASANTON, Calif., Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica's success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.

Key Points: 
  • PLEASANTON, Calif., Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control.
  • Vault LIMS builds on Civica's success with Veeva Vault QMS , Veeva Vault QualityDocs , and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.
  • Within Vault LIMS, lab professionals will be able to reference relevant methods and specifications stored in Vault QualityDocs and surface relevant quality events from Vault QMS during final QC review.
  • "Veeva Vault LIMS will help Civica create an advanced quality control lab with a simple and efficient user experience," said Jason Boyd, senior director, Veeva Vault LIMS.

Veeva Vault LIMS to Support Civica Rx Quality Control

Retrieved on: 
Tuesday, August 22, 2023

BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control. Vault LIMS builds on Civica's success with Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.

Key Points: 
  • BARCELONA, Spain, Aug. 22, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Civica Rx (Civica) has adopted Veeva Vault LIMS to optimize quality control.
  • Vault LIMS builds on Civica's success with Veeva Vault QMS , Veeva Vault QualityDocs , and Veeva Vault Training and establishes a foundation for unified lab and quality processes to support a new manufacturing facility.
  • Within Vault LIMS, lab professionals will be able to reference relevant methods and specifications stored in Vault QualityDocs and surface relevant quality events from Vault QMS during final QC review.
  • "Veeva Vault LIMS will help Civica create an advanced quality control lab with a simple and efficient user experience," said Jason Boyd, senior director, Veeva Vault LIMS.

Jay Benson Joins Civica Rx as Chief Manufacturing and Supply Chain Officer

Retrieved on: 
Tuesday, June 13, 2023

Civica Inc. (Civica, Civica Rx) today announced that biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer.

Key Points: 
  • Civica Inc. (Civica, Civica Rx) today announced that biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer.
  • Benson has 30 years of experience within the biopharmaceutical industry, including clinical and commercial manufacturing, global strategy development, and tech transfer and commercialization of new therapies.
  • “Jay takes the torch from Russ Gall, who has been with Civica from inception,” added McCoy.
  • “We thank Russ for his many years of service to Civica, our partners and patients and wish him well in his retirement.”

California Selects Civica Rx as Its Insulin Manufacturing Partner

Retrieved on: 
Saturday, March 18, 2023

Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work.

Key Points: 
  • Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work.
  • “California’s partnership with Civica is a game changer,” said California Governor Gavin Newsom.
  • Civica and CalRx have the mutual goal of ensuring access to affordable insulins that have single, low transparent prices.
  • The next phase of this partnership is assessing options for the standup of an insulin manufacturing facility in California and further efforts to disrupt the insulin market and provide additional benefits for patients who depend on this life saving drug.

Out of Control: U.S. Employers Spend $245B a Year on Diabetes as Diagnosis Rates Rise, New Nomi Health Data Shows

Retrieved on: 
Tuesday, March 14, 2023

Diabetes costs U.S. employers approximately $245 billion a year — more than double what the entire American automotive industry is worth, according to new data announced today by Nomi Health .

Key Points: 
  • Diabetes costs U.S. employers approximately $245 billion a year — more than double what the entire American automotive industry is worth, according to new data announced today by Nomi Health .
  • As part of the Nomi Health Trends in Spend Tracker — a series using claims analysis data to call attention and action to key shifts in healthcare costs — Nomi Health analyzed nearly half a million employer health insurance claims to reveal changes in employer spend on diabetes.
  • We must turn these spend insights into meaningful action,” Nomi Health Co-founder and CEO Mark Newman said.
  • Previous Nomi Health Trends in Spend Trackers explored pediatric mental health utilization and the costs of long COVID , which outpaced diabetes in 2022 employer health care costs.

Nomi Health Launches Charitable Foundation to Expand Access to Affordable, High-Quality Healthcare

Retrieved on: 
Thursday, February 23, 2023

Nomi Health , a direct healthcare company, has announced the creation of the Nomi Health Charitable Foundation to advance the company’s efforts to expand access to high-quality affordable healthcare across the United States.

Key Points: 
  • Nomi Health , a direct healthcare company, has announced the creation of the Nomi Health Charitable Foundation to advance the company’s efforts to expand access to high-quality affordable healthcare across the United States.
  • “Our mission at Nomi Health is to rewire the U.S. healthcare system to run at half the cost while increasing access for all.
  • That’s why we’re launching the Nomi Health Charitable Foundation to formalize our years-long commitment to take on the deeply rooted inequalities in our broken healthcare system and to uplift those who have been left behind.”
    Through philanthropic investments and partnerships, the Nomi Health Charitable Foundation will focus on four key areas of impact:
    Healthcare Equity: Nomi Health focuses on addressing health disparities by increasing access to affordable, high-quality care – including mental healthcare.
  • The Nomi Health Charitable Foundation is launching a new signature program – The Frontline Futures Program – to support students and young professionals pursuing careers in healthcare.